Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT01663220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2013-08-14
Summary
A multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mellitus.
Conditions
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Juvenile Diabetes Research Foundation
collaborator OTHER -
Amylin Pharmaceuticals, LLC.
collaborator INDUSTRY - collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
-
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
collaborator INDUSTRY - collaborator INDUSTRY
-
Foundation for the National Institutes of Health
lead OTHER
Principal Investigators
-
George Atiee, MD · ICON Development Solutions
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- United States
Study Locations
More Related Trials
-
Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
NCT01790308 ·Status: UNKNOWN ·Phase: PHASE4
-
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
NCT01722266 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
NCT01300260 ·Status: COMPLETED ·Phase: PHASE1
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
NCT01449019 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Secretion in Diabetes Before and After Glycemic Control
NCT00469833 ·Status: COMPLETED ·Phase: NA
-
The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).
NCT00361946 ·Status: COMPLETED
-
A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1
NCT02221323 ·Status: COMPLETED ·Phase: PHASE2
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes
NCT06671340 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Severe Insulin Resistance in Patients With Type 2 Diabetes
NCT00654056 ·Status: COMPLETED ·Phase: NA
-
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
NCT00655603 ·Status: UNKNOWN ·Phase: NA
-
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
NCT01686945 ·Status: COMPLETED ·Phase: PHASE1
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
NCT06825182 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes
NCT04133922 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
NCT05502562 ·Status: COMPLETED
-
Circulating Biomarkers in the Development of Type 1 Diabetes
NCT05505669 ·Status: RECRUITING
-
To Determine Tolerability to Glucagon Infusion in Obese Subjects
NCT02817659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
NCT03509324 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
NCT01619345 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States
NCT02987335 ·Status: COMPLETED
-
The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans
NCT01953393 ·Status: COMPLETED ·Phase: NA
-
Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes
NCT04466618 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
NCT01509742 ·Status: COMPLETED ·Phase: PHASE1